Cargando…

Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation

Detalles Bibliográficos
Autores principales: Ueno, Toshiyuki, Ohta, Takanori, Sugio, Yasuhiro, Ohno, Yuju, Uehara, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907387/
https://www.ncbi.nlm.nih.gov/pubmed/35273388
http://dx.doi.org/10.1038/s41409-022-01633-6
_version_ 1784665629598416896
author Ueno, Toshiyuki
Ohta, Takanori
Sugio, Yasuhiro
Ohno, Yuju
Uehara, Yasufumi
author_facet Ueno, Toshiyuki
Ohta, Takanori
Sugio, Yasuhiro
Ohno, Yuju
Uehara, Yasufumi
author_sort Ueno, Toshiyuki
collection PubMed
description
format Online
Article
Text
id pubmed-8907387
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89073872022-03-10 Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation Ueno, Toshiyuki Ohta, Takanori Sugio, Yasuhiro Ohno, Yuju Uehara, Yasufumi Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-03-10 2022 /pmc/articles/PMC8907387/ /pubmed/35273388 http://dx.doi.org/10.1038/s41409-022-01633-6 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Ueno, Toshiyuki
Ohta, Takanori
Sugio, Yasuhiro
Ohno, Yuju
Uehara, Yasufumi
Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation
title Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation
title_full Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation
title_fullStr Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation
title_full_unstemmed Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation
title_short Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation
title_sort severe acute interstitial lung disease after bnt162b2 mrna covid-19 vaccination in a patient post hla-haploidentical hematopoietic stem cell transplantation
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907387/
https://www.ncbi.nlm.nih.gov/pubmed/35273388
http://dx.doi.org/10.1038/s41409-022-01633-6
work_keys_str_mv AT uenotoshiyuki severeacuteinterstitiallungdiseaseafterbnt162b2mrnacovid19vaccinationinapatientposthlahaploidenticalhematopoieticstemcelltransplantation
AT ohtatakanori severeacuteinterstitiallungdiseaseafterbnt162b2mrnacovid19vaccinationinapatientposthlahaploidenticalhematopoieticstemcelltransplantation
AT sugioyasuhiro severeacuteinterstitiallungdiseaseafterbnt162b2mrnacovid19vaccinationinapatientposthlahaploidenticalhematopoieticstemcelltransplantation
AT ohnoyuju severeacuteinterstitiallungdiseaseafterbnt162b2mrnacovid19vaccinationinapatientposthlahaploidenticalhematopoieticstemcelltransplantation
AT ueharayasufumi severeacuteinterstitiallungdiseaseafterbnt162b2mrnacovid19vaccinationinapatientposthlahaploidenticalhematopoieticstemcelltransplantation